Douglas Williams

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Camp4 Therapeutics Corp publishes a filing, an earnings call transcript or a press release.

Get CAMP alerts

About Douglas Williams

Douglas Williams is recorded as Board Member at Camp4 Therapeutics Corp (CAMP) and Board Member at Climb Bio, Inc. (CLYM) since June 5, 2026. The newest filing on record that lists Douglas Williams as Board Member at Camp4 Therapeutics Corp (CAMP) is dated April 23, 2026. Climb Bio, Inc. reported in an 8-K filed June 8, 2026 that Douglas Williams was appointed Director, effective June 5, 2026. Camp4 Therapeutics Corp is classified in the Biotechnology industry within the Healthcare sector. Climb Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Camp4 Therapeutics Corp includes Josh Mandel-Brehm (CEO and Board Member), Doug Williams (Chairman), Kelly Gold (CFO) and 7 others.

“The stockholders of the Company elected Alexander (Bo) Cumbo and Douglas Williams, Ph.D., to the Company's Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified.”

Climb Bio, Inc. Form 8-K, filed June 8, 2026 · Read the filing

Affiliation history

Climb Bio, Inc. (CLYM)
Board Member

SEC 8-K

Current
2026-06-05–present
Camp4 Therapeutics Corp (CAMP)
Board Member

Proxy statement

Current
Start not stated–present

Last confirmed April 23, 2026